Clinical Trials Directory

Trials / Completed

CompletedNCT05127837

CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

Development of an Artificial Intelligence- Informed Digital Tool to Help Clinicians Practice Cognitive Behavioral Therapy for Psychosis (CBTp)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
601 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this grant is to develop and evaluate an Artificial Intelligence-based clinical training tool--CBTpro--to support high-quality skills training in CBT for psychosis (CBTp). CBTpro will provide a rapid means of scaling and sustaining high-quality CBTp in routine care settings across the US.

Detailed description

This fast-track Small Business Technology Transfer (STTR) grant is a partnership between the University of Washington and private company LYSSN that includes the development and iterative testing of CBTpro, a Computerized Clinician Support Tool designed to teach behavioral health providers and students Cognitive Behavioral Therapy for psychosis (CBTp). CBTpro uses natural language processing to provide automated speech-to-text and machine learning to score trainee's responses to simulated patients with psychosis. Once technical reliability of the tool is achieved through iterative modifications based on usability and field trials, a randomized control trial will be conducted to assess CBTpro training vs. training as usual with N=100 providers / N=300 clients on clinician skills and client outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCBTproCBTpro is a novel spoken language technology tool to support high-quality skills training in CBT for psychosis.

Timeline

Start date
2022-06-28
Primary completion
2024-12-09
Completion
2024-12-09
First posted
2021-11-19
Last updated
2026-02-27
Results posted
2026-02-27

Locations

13 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05127837. Inclusion in this directory is not an endorsement.